- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05805865
Efficacy of Eco-Friendly Toothpaste Tablets Versus Conventional Toothpaste Using PI and GI Index
Objectives: To assess the change in gingival index (GI) and plaque index (PI) when comparing the use of toothpaste tablets to conventional toothpaste.
Methods: 40 participants were randomized into two groups: Colgate's toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (C). Both groups utilized their assigned dentifrice for 2 weeks. A pre and post-assessment measured the GI and PI index. A questionnaire on the use of the product was distributed.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
California
-
Loma Linda, California, United States, 92350
- Loma Linda University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects are 18 years or older;
- Subjects who will comply with study protocol;
- Subjects who can read and understand the consent form;
- Subjects available during the study period;
- Subjects have more than 20 teeth.
Exclusion Criteria:
- Subjects who are pregnant and/or nursing;
- Subjects under the age of 18.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Toothpaste Tablet
Subjects are instructed to use one toothpaste tablet for brushing.
Brushing is recommended twice daily for two minutes.
|
Colgate Anywhere Toothpaste Tablets
|
|
Active Comparator: Conventional Toothpaste
Subjects are instructed to use the toothpaste for brushing.
Brushing is recommended twice daily for two minutes.
|
Colgate Cavity Protection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plaque Index Score at Baseline
Time Frame: Change between baseline at visit 1 and visit 2, two weeks post baseline.
|
Plaque was scored according to the Turesky modification of the Quigley-Hein Plaque Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. Plaque was disclosed and scored on each tooth surface according to the following criteria: 0: No plaque.
Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth. |
Change between baseline at visit 1 and visit 2, two weeks post baseline.
|
|
Gingival Index Score at Baseline
Time Frame: Change between baseline at visit 1 and visit 2, two weeks post baseline.
|
Gingivitis was scored according to the Löe-Silness Gingival Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. The gingiva adjacent to each tooth surface was scored as follows: 0 = Absence of inflammation.
Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth. |
Change between baseline at visit 1 and visit 2, two weeks post baseline.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subject Perception of Product Use
Time Frame: Visit 2 two weeks post study enrollment
|
This is a composite measurement based on questionnaire response.
Subjects will answer 7 questions related to cleanliness, flavor, ease of use, eco-friendliness, willingness to switch, satisfaction, texture.
This is measured on a Likert Scale from 1-4. 1 represents strongly agree with overall product satisfaction.
4 represents strongly disagree with overall product satisfaction.
|
Visit 2 two weeks post study enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: So Ran Kwon, DDS, MS, PhD, Loma Linda University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5220342
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Inflammation
-
Cairo UniversityCompleted
-
Tufts UniversityCompletedGingival InflammationUnited States
-
King Abdullah University HospitalJordan University of Science and TechnologyRecruitingGingivitis | Dental Plaque | Gingival Inflammation | Gingival Bleeding | Patient Reported Outcome | Gingival Inflammation and BleedingJordan
-
Church & Dwight Company, Inc.CompletedDental Plaque | Gingival Inflammation and BleedingCanada
-
University of WashingtonRecruitingWhite Spot Lesions | Gingival Inflammation and BleedingUnited States
-
Melaka Manipal Medical CollegeColgate PalmoliveCompletedPlaque | Gingival Inflammation | Gingival Bleeding | Plaque ControlMalaysia
-
Inonu UniversityRecruitingGingival Diseases | Gingival Recession | Gingival InflammationTurkey
-
Izun Pharma LtdSuspendedGingival Inflammation in Diabetic PatientsIsrael
-
Colgate PalmoliveThe University of Texas Health Science Center, HoustonNot yet recruitingGingival InflammationUnited States
-
Universidad Autonoma de San Luis PotosíCompleted
Clinical Trials on Toothpaste Tablet
-
Loma Linda UniversityNot yet recruitingDental Caries | Gingival InflammationUnited States
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
HALEONCompletedDentin HypersensitivityUnited States
-
Çankırı Karatekin UniversityCompleted
-
The University of Texas Health Science Center at...Sangi Co., Ltd.CompletedDentin SensitivityUnited States
-
Lacer S.A.Not yet recruiting
-
Unilever R&DRecruitingDental Plaque | Gingival Inflammation | Gingival BleedingIndonesia
-
HALEONCompletedGingivitisUnited Kingdom
-
King Abdulaziz UniversityRecruitingMolar-Incisor Hypomineralization (MIH)Saudi Arabia